Ending Cervical Cancer in Canada is Possible
The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s elimination goal in this country. The plan is to reach full HPV vaccination of boys and girls; to move to primary HPV testing plus offer self-sampling in cervical screening programs; and to ensure rigorous follow up when abnormalities are identified. This will advance women’s health and lead to the elimination of cervical cancer in Canada by 2040. Read more at partnershipagainstcancer.ca/cervical.
Endowed Chair in Palliative Care Research
The Faculty of Medicine at Dalhousie University is pleased to invite applications for the QEII Foundation Endowed Chair in Palliative Care Research. The successful candidate for the Chair position will engage in palliative care research, as well as... Read More »
The Faculty of Medicine at Dalhousie University is pleased to invite applications for the QEII Foundation Endowed Chair in Palliative Care Research. The successful candidate for the Chair position will engage in palliative care research, as well as... Read More »
New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute... Read More »
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute... Read More »